Jan Lindemans

Homocysteine Levels and the Risk of Osteoporotic Fracture

Joyce B. J. van Meurs, R.A.M. Dhonukshe-Rutten, Saskia M.F. Pluijm et al. · New England Journal of Medicine · 2004 · 743 citations · Full text

Periconceptional Maternal Folic Acid Use of 400 µg per Day Is Related to Increased Methylation of the IGF2 Gene in the Very Young Child

Régine P.M. Steegers‐Theunissen, Sylvia A Obermann-Borst, Dennis Kremer et al. · PLoS ONE · 2009 · 454 citations · Full text

Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience

Roelf Valkema, Marion de Jong, Willem H. Bakker et al. · Seminars in Nuclear Medicine · 2002 · 430 citations

Medicine, Radionuclide Therapy, Peptide Library +8

Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification

Maryam Kavousi, Suzette Elias‐Smale, Joost H.W. Rutten et al. · Annals of Internal Medicine · 2012 · 363 citations

Chromogranin A as Serum Marker for Neuroendocrine Neoplasia: Comparison with Neuron-Specific Enolase and the α-Subunit of Glycoprotein Hormones

Frank Nobels, Dik J. Kwekkeboom, Willy Coopmans et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 353 citations